絞り込み

16506

広告

NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.

著者 Bertaglia E , Anselmino M , Zorzi A , Russo V , Toso E , Peruzza F , Rapacciuolo A , Migliore F , Gaita F , Cucchini U , De Divitiis M , Iliceto S , Stabile G
Int J Cardiol.2017 Dec 15 ; 249():179-183.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (35view , 0users)

Full Text Sources

Miscellaneous

Despite optimal oral anticoagulation with vitamin K antagonist, left atrial (LA) thrombus could be detected in the left appendage (LAA) in >2% of patients with atrial fibrillation (AF) and CHA2DS2-VASc score≥1 but few data are available for patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). We evaluated the occurrence and predictors of LA thrombi by means of transesophageal echocardiography (TOE) in consecutive patients with non-valvular AF who received for at least 3weeks Apixaban, Dabigatran, or Rivaroxaban.
PMID: 29121724 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード